State of Wisconsin Investment Board’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
NAMA
AIM
SSA
State of Wisconsin Investment Board's ARCT Position: Q3 2025 in Review
State of Wisconsin Investment Board sold out of Arcturus Therapeutics (ARCT) in Q3 2025, closing a stake of 100,098 shares — an estimated $1.3M sold.
State of Wisconsin Investment Board first reported a position in ARCT in Q3 2020 and held it in 20 quarters. The position peaked at $1.91M in Q1 2024. 136 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.
- State of Wisconsin Investment Board reported no remaining Arcturus Therapeutics position as of Q3 2025 after selling out during the quarter.
- State of Wisconsin Investment Board sold 100,098 Arcturus Therapeutics shares in Q3 2025, an estimated $1.3M.
- State of Wisconsin Investment Board first reported a position in Arcturus Therapeutics in Q3 2020 and held it in 20 quarters.
- State of Wisconsin Investment Board's Arcturus Therapeutics position peaked at $1.91M in Q1 2024.
- 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.
Based on State of Wisconsin Investment Board's 13F filing for Q3 2025, filed 14 Nov 2025.